These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28165800)

  • 1. Rising cost of antidotes in the U.S.: cost comparison from 2010 to 2015.
    Heindel GA; Trella JD; Osterhoudt KC
    Clin Toxicol (Phila); 2017 Jun; 55(5):360-363. PubMed ID: 28165800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antidote availability in Norway].
    Solheim L; Andrew E; Jacobsen D
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1111-3. PubMed ID: 12043055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of antidotes at acute care hospitals in Ontario.
    Juurlink DN; McGuigan MA; Paton TW; Redelmeier DA
    CMAJ; 2001 Jul; 165(1):27-30. PubMed ID: 11468950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of antidote stocking in British Columbia hospitals: the 2005 Antidote Stocking Study.
    Wiens MO; Zed PJ; Lepik KJ; Abu-Laban RB; Brubacher JR; Gorman SK; Kent DA; Purssell RA
    CJEM; 2006 Nov; 8(6):409-16. PubMed ID: 17209490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National audit of antidote stocking in acute hospitals in the UK.
    Thanacoody RH; Aldridge G; Laing W; Dargan PI; Nash S; Thompson JP; Vale A; Bateman N; Thomas S
    Emerg Med J; 2013 May; 30(5):393-6. PubMed ID: 22875840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency Care.
    Dart RC; Goldfrank LR; Erstad BL; Huang DT; Todd KH; Weitz J; Bebarta VS; Caravati EM; Henretig FM; Delbridge TR; Banner W; Schneider SM; Anderson VE
    Ann Emerg Med; 2018 Mar; 71(3):314-325.e1. PubMed ID: 28669553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care.
    Dart RC; Borron SW; Caravati EM; Cobaugh DJ; Curry SC; Falk JL; Goldfrank L; Gorman SE; Groft S; Heard K; Miller K; Olson KR; O'Malley G; Seger D; Seifert SA; Sivilotti ML; Schaeffer T; Tomassoni AJ; Wise R; Bogdan GM; Alhelail M; Buchanan J; Hoppe J; Lavonas E; Mlynarchek S; Phua DH; Rhyee S; Varney S; Zosel A;
    Ann Emerg Med; 2009 Sep; 54(3):386-394.e1. PubMed ID: 19406507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National study on the adequacy of antidotes stocking in Lebanese hospitals providing emergency care.
    Mansour A; Al-Bizri L; El-Maamary J; Al-Helou A; Hamade R; Saliba E; Khammash D; Makhoul K; Matli K; Ghosn N; Deeb M; Faour WH
    BMC Pharmacol Toxicol; 2016 Nov; 17(1):51. PubMed ID: 27817746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A system-wide solution to antidote stocking in emergency departments: the Nova Scotia antidote program.
    Murphy NG; Bona DR; Hurley TA
    CJEM; 2019 Jan; 21(1):37-46. PubMed ID: 28927481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States.
    Dart RC; Goldfrank LR; Chyka PA; Lotzer D; Woolf AD; McNally J; Snodgrass WR; Olson KR; Scharman E; Geller RJ; Spyker D; Kraft M; Lipsy R
    Ann Emerg Med; 2000 Aug; 36(2):126-132. PubMed ID: 10918103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate stocking of antidotes in Taiwan: is it a serious problem?
    Ong HC; Yang CC; Deng JF
    J Toxicol Clin Toxicol; 2000; 38(1):21-8. PubMed ID: 10696920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluate the impact of hospital types on the availability of antidotes for the management of acute toxic exposures and poisonings in Malaysia.
    Al-Sohaim SI; Awang R; Zyoud SH; Rashid SM; Hashim S
    Hum Exp Toxicol; 2012 Mar; 31(3):274-81. PubMed ID: 21478291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can emergency departments not afford to carry essential antidotes?
    Sivilotti ML; Eisen JS; Lee JS; Peterson RG
    CJEM; 2002 Jan; 4(1):23-33. PubMed ID: 17637145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Price analysis of multiple sclerosis disease-modifying therapies marketed in the United States.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Nov; 32(11):1783-1788. PubMed ID: 27359262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of antidotes for the treatment of acute poisoning in Queensland public hospitals.
    Nissen LM; Wong KH; Jones A; Roberts DM
    Aust J Rural Health; 2010 Apr; 18(2):78-84. PubMed ID: 20398048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the price benchmark to replace average wholesale price (AWP)?
    Curtiss FR; Lettrich P; Fairman KA
    J Manag Care Pharm; 2010 Sep; 16(7):492-501. PubMed ID: 20726678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of antidotes in hospital pharmacies in Greece.
    Plataki M; Anatoliotakis N; Tzanakis N; Assithianakis P; Tsatsakis AM; Bouros D
    Vet Hum Toxicol; 2001 Apr; 43(2):103-5. PubMed ID: 11308116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient stocking of poisoning antidotes in hospital pharmacies.
    Dart RC; Stark Y; Fulton B; Koziol-McLain J; Lowenstein SR
    JAMA; 1996 Nov; 276(18):1508-10. PubMed ID: 8903263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of the stocking of poison antidotes in Alabama hospitals.
    Teresi WM; King WD
    South Med J; 1999 Dec; 92(12):1151-6. PubMed ID: 10624904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes.
    Mazer-Amirshahi M; Stolbach A; Nelson LS
    J Med Toxicol; 2018 Jun; 14(2):168-171. PubMed ID: 29185196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.